Alyeska Investment Group’s Solid Biosciences SLDB Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $7.99M | Hold |
1,640,821
| – | – | 0.03% | 375 |
|
|
2025
Q1 | $6.07M | Buy |
1,640,821
+1,294,450
| +374% | +$4.79M | 0.02% | 347 |
|
|
2024
Q4 | $1.39M | Hold |
346,371
| – | – | 0.01% | 481 |
|
|
2024
Q3 | $2.41M | Sell |
346,371
-100,000
| -22% | -$697K | 0.01% | 404 |
|
|
2024
Q2 | $2.53M | Buy |
446,371
+31,756
| +8% | +$180K | 0.01% | 381 |
|
|
2024
Q1 | $5.52M | Sell |
414,615
-222,664
| -35% | -$2.97M | 0.03% | 312 |
|
|
2023
Q4 | $3.91M | Sell |
637,279
-9,325
| -1% | -$57.3K | 0.03% | 315 |
|
|
2023
Q3 | $1.63M | Hold |
646,604
| – | – | 0.01% | 383 |
|
|
2023
Q2 | $3.39M | Hold |
646,604
| – | – | 0.03% | 349 |
|
|
2023
Q1 | $3.06M | Buy |
646,604
+106,457
| +20% | +$505K | 0.03% | 320 |
|
|
2022
Q4 | $2.89M | Sell |
540,147
-1
| -0% | -$5 | 0.03% | 297 |
|
|
2022
Q3 | $3.74M | Buy |
540,148
+442,198
| +451% | +$3.06M | 0.04% | 278 |
|
|
2022
Q2 | $904K | Buy |
97,950
+10,000
| +11% | +$92.3K | 0.01% | 501 |
|
|
2022
Q1 | $1.58M | Buy |
87,950
+20,000
| +29% | +$360K | 0.02% | 457 |
|
|
2021
Q4 | $1.78M | Buy |
67,950
+9,040
| +15% | +$237K | 0.02% | 457 |
|
|
2021
Q3 | $2.11M | Buy |
58,910
+24,834
| +73% | +$890K | 0.03% | 490 |
|
|
2021
Q2 | $1.87M | Hold |
34,076
| – | – | 0.02% | 529 |
|
|
2021
Q1 | $2.83M | Buy |
+34,076
| New | +$2.83M | 0.04% | 404 |
|
|
2018
Q2 | – | Sell |
-7,457
| Closed | -$839K | – | 477 |
|
|
2018
Q1 | $839K | Buy |
+7,457
| New | +$839K | 0.01% | 365 |
|